- $108.96m
- -$107.89m
- $254.36m
- 54
- 71
- 73
- 73
Growth & Value
| 12m Forecast Rolling | Industry | Market | |
|---|---|---|---|
| PE Ratio (f) | n/a | ||
| PEG Ratio (f) | n/a | ||
| EPS Growth (f) | n/a | ||
| Dividend Yield (f) | n/a | ||
| Valuation (ttm) | Industry | Market | |
|---|---|---|---|
| Price to Book Value | 0.36 | ||
| Price to Tang. Book | 0.54 | ||
| Price to Free Cashflow | n/a | ||
| Price to Sales | 0.43 | ||
| EV to EBITDA | n/a | ||
Shareholder Activity
| Type | Buy / Hold / Sell |
|---|---|
| Institutions | |
| Directors | |
| Community |
Guru Screens
Quality
| Name | Industry | Market | |
|---|---|---|---|
| Return on Capital | -66.99% | ||
| Return on Equity | -54.13% | ||
| Operating Margin | -85.52% | ||
Financial Summary
| Year End 31st Dec | Unit | 2020 | 2021 | 2022 | 2023 | 2024 | 2025E | 2026E | CAGR / Avg |
|---|---|---|---|---|---|---|---|---|---|
| Total Revenue | $m | 245.26 | 252.79 | 277.19 | 259.05 | 254.36 | 255.07 | 280.73 | 11.31% |
| Operating Profit | m | ||||||||
| Net Profit | m | ||||||||
| EPS Reported | |||||||||
| Diluted Normalised EPS | |||||||||
| EPS Growth | % | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
| PE Ratio | x | ||||||||
| PEG | |||||||||
| Profitability | |||||||||
| Operating Margin | % | ||||||||
| ROA | % | ||||||||
| ROCE | % | ||||||||
| ROE | % | ||||||||
| Cashflow | |||||||||
| Op. Cashflow ps | |||||||||
| Capex ps | |||||||||
| Free Cashflow ps | |||||||||
| Dividends | |||||||||
| Dividend ps | |||||||||
| Dividend Growth | % | ||||||||
| Dividend Yield | % | ||||||||
| Dividend Cover | x | ||||||||
| Balance Sheet | |||||||||
| Cash etc | m | ||||||||
| Working Capital | m | ||||||||
| NFA | m | ||||||||
| Net Debt | m | ||||||||
| Book Value | m | ||||||||
| Diluted Weighted Average Shares | m | ||||||||
| Book Value ps | |||||||||
Other Ratios
| Leverage (ttm) | Total | - Intang | + Pension |
|---|---|---|---|
| Gross Gearing | |||
| Net Gearing | |||
| Cash / Assets |
| Liquidity (ttm) | |
|---|---|
| Curr. Ratio | |
| Quick Ratio | |
| Interest Cov. | |
| Efficiency (ttm) | |
|---|---|
| Asset Turnover | |
| Recs Turnover | |
| Stock Turnover | |
Recent History
| Latest interim period vs. prior period | Industry | Market | |
|---|---|---|---|
| Sales Growth | |||
| EPS Growth | |||
| 3yr Compound Annual Growth Rate | Industry | Market | |
|---|---|---|---|
| Sales CAGR | |||
| EPS CAGR | |||
| DPS CAGR | |||
Profile Summary
American Well Corporation operates a hybrid care, delivery enablement platform in the United States and globally, connecting and enabling providers, payers, patients, and innovators to deliver access to more affordable quality care. It offers a single, comprehensive platform to support all digital health needs from urgent to acute and post-acute care, as well as chronic care management and healthy living. The Amwell Converge platform offers data architecture and video capabilities, flexibility and scalability, as well as a user experience focused on the needs of patients, members and providers. For health systems, its enterprise platform enables provider-to-provider virtual care for use cases ranging from stroke to virtual nursing and e-sitting. Its Amwell Carepoint devices enable healthcare providers to leverage proprietary carts and transform existing tablets and TVs into digital access points in clinical settings, helping to address personnel shortages and access limitations.
Directors
- Ido Schoenberg CHM (56)
- Roy Schoenberg PRE (52)
- Robert Shepardson CFO (57)
- Phyllis Gotlib CEX (64)
- Kurt Knight COO (42)
- Amber Howe CHO (44)
- Bradford Gay SVP (45)
- Serkan Kutan CTO (44)
- Jason Medeiros CIO (47)
- Mary Modahl CMO (58)
- Brendan O'Grady OTH (54)
- Delos Cosgrove IND (80)
- Deborah Jackson IND (69)
- Deval Patrick IND (64)
- Derek Ross IND (49)
- Stephen Schlegel IND (58)
- Peter Slavin IND (63)
- Last Annual
- December 31st, 2024
- Last Interim
- December 31st, 2024
- Incorporated
- June 1st, 2006
- Public Since
- September 17th, 2020
- No. of Shareholders
- 153
- No. of Employees
- 877
- Sector
- Healthcare Providers & Services
- Industry
- Healthcare
- Exchange
New York Stock Exchange- Shares in Issue
- 15,609,990
- Address
- 75 STATE STREET, 26TH FLOOR, BOSTON, 02109
- Web
- https://business.amwell.com/
- Phone
- +1 6172053500
- Auditors
- PricewaterhouseCoopers LLP
Upcoming Events for AMWL
Q1 2025 American Well Corp Earnings Call
American Well Corp Annual Shareholders Meeting
Q2 2025 American Well Corp Earnings Release
Similar to AMWL
Agilon Health
New York Stock Exchange
AMN Healthcare Services
New York Stock Exchange
Ardent Health Partners
New York Stock Exchange
Auna SA
New York Stock Exchange
Brookdale Senior Living
New York Stock Exchange
FAQ
What is the AMERICAN WELL share price?
As of Today at 19:14 UTC, shares in AMERICAN WELL are trading at $6.98. This share price information is delayed by 15 minutes.
How has the AMERICAN WELL share price performed this year?
Shares in AMERICAN WELL last closed at $6.98 and the price had moved by -32.09% over the past 365 days. In terms of relative price strength the AMERICAN WELL share price has underperformed the S&P500 Index by -36.14% over the past year.
What are the analyst and broker recommendations for AMERICAN WELL?
The overall consensus recommendation for AMERICAN WELL is Hold. You can view the full broker recommendation list by unlocking its StockReport.
Find out moreWhat is the AMERICAN WELL dividend yield?
AMERICAN WELL does not currently pay a dividend.
Does AMERICAN WELL pay a dividend?
AMERICAN WELL does not currently pay a dividend.
When does AMERICAN WELL next pay dividends?
AMERICAN WELL does not currently pay a dividend.
How do I buy AMERICAN WELL shares?
To buy shares in AMERICAN WELL you'll need a share-dealing account with an online or offline stock broker. Once you have opened your account and transferred funds into it, you'll be able to search and select shares to buy and sell. You can use Stockopedia’s share research software to help you find the the kinds of shares that suit your investment strategy and objectives.
What is the market cap of AMERICAN WELL?
As of the previous close price of $6.98, shares in AMERICAN WELL had a market capitalisation of $108.96m.
Where are AMERICAN WELL shares listed?
Here are the trading details for AMERICAN WELL:
- Country of listing: United States
- Exchange: NYQ
- Ticker Symbol: AMWL
What kind of share is AMERICAN WELL?
Based on an overall assessment of its quality, value and momentum AMERICAN WELL is currently classified as a Neutral. The classification is based on a composite score that examines a wide range of fundamental and technical measures. Stock are classified on the the following spectrum: Super Stocks, High Flyers, Contrarians, Turnarounds, Neutral, Value Traps, Momentum Traps, Falling Stars, and Sucker Stocks. For more information, learn about our StockRank Styles.
Is there a AMERICAN WELL share price forecast for 2025?
The analyst consensus target price for shares in AMERICAN WELL is $10.87. That is 55.73% above the last closing price of $6.98.
Analysts covering AMERICAN WELL currently have a consensus Earnings Per Share (EPS) forecast of -$8.40 for the next financial year.
Find out moreWhat is the trend in the AMERICAN WELL share price?
An important predictor of whether a stock price will go up is its track record of momentum. Price trends tend to persist, so it's worth looking at them when it comes to a share like AMERICAN WELL. Over the past six months, its share price has underperformed the S&P500 Index by -25.2%.
As of the last closing price of $6.98, shares in AMERICAN WELL were trading -21.51% below their 200 day moving average. You can read more about the power of momentum in assessing share price movements on Stockopedia.
What is the AMERICAN WELL PE Ratio?
The AMERICAN WELL PE ratio based on its reported earnings over the past 12 months is null. The shares last closed at $6.98.
The PE ratio (or price-to-earnings ratio) is the one of the most popular valuation measures used by stock market investors. It is calculated by dividing a company's price per share by its earnings per share.
The PE ratio can be seen as being expressed in years, in the sense that it shows the number of years of earnings which would be required to pay back the purchase price, ignoring inflation. So in general terms, the higher the PE, the more expensive the stock is.
Who are the key directors of AMERICAN WELL?
AMERICAN WELL's management team is headed by:
- Ido Schoenberg - CHM
- Roy Schoenberg - PRE
- Robert Shepardson - CFO
- Phyllis Gotlib - CEX
- Kurt Knight - COO
- Amber Howe - CHO
- Bradford Gay - SVP
- Serkan Kutan - CTO
- Jason Medeiros - CIO
- Mary Modahl - CMO
- Brendan O'Grady - OTH
- Delos Cosgrove - IND
- Deborah Jackson - IND
- Deval Patrick - IND
- Derek Ross - IND
- Stephen Schlegel - IND
- Peter Slavin - IND